Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Kosmos Energy swings to Q4 profit despite fall in sales

(Sharecast News) - American oil group Kosmos Energy reported that fourth-quarter revenues fell by a tenth as falling prices outweighed an increase in production, but the company swung to a profit and painted a bullish outlook for the coming year. Total revenues were $507.8m in the three months to 31 December, down 9.9% from the $563.7m reported a year earlier, as the average sales price per barrel of oil equivalents slipped to $75.64 from $81.70.

However, total oil and gas production costs fell to $103.8m from $125.8m previously, and a big drop in the impairment of long-lived assets to $222.3m from $450.0m meant that pre-tax income totalled $41.4m, compared with a loss of $199.9m the year before.

For the full year, Kosmos booked a pre-tax income of $371.7m, up from $337.1m in 2022, but revenues fell to $1.70bn from $2.30bn.

Net production in the fourth quarter was 66,000 barrels of oil equivalent per day (boepd), representing around 12% growth year-on-year.

The company said it continued to advance its key development projects during the quarter, which it hopes will increase production by 50% compared with the second half of 2022.

"The start-up of Jubilee Southeast was a major step toward achieving this goal and, in the coming months, we expect production to begin at Winterfell in the Gulf of Mexico followed by first gas at Greater Tortue Ahmeyim offshore Mauritania and Senegal," said chair and chief executive Andrew Inglis.

"As we pursue these operated developments, as well as other projects in our organic portfolio, we are confident in our ability to deliver growth through the decade while generating strong cash flow. This is expected to strengthen our balance sheet, help us achieve our leverage targets, while providing flexibility around future capital allocation opportunities including returns to shareholders."

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.